INTRODUCTION

Breast Cancer is an enormous public health challenge worldwide in both the developed and less developed world, with nearly 1.7 million new cases diagnosed in 2012 (second most common cancer overall). This represents about 12% of all new cancer cases and 25% of all cancers in women. It is estimated that worldwide over 508 000 women died in 2011 due to breast cancer (Global Health Estimates, WHO 2013). Although breast cancer is thought to be a disease of the developed world, almost 50% of breast cancer cases and 58% of deaths occur in less developed countries (GLOBOCAN 2008). Incidence rates also vary greatly worldwide from 19.3 per 100,000 women in Eastern Africa to 89.7 per 100,000 women in Western Europe. In most of the developing regions the incidence rates are below 40 per 100,000 (GLOBOCAN 2008). The lowest incidence rates are found in most African countries but here breast cancer incidence rates are also increasing.

ABOUT US

WHO WE ARE

breast IT is a revolutionary diagnosis tool for breast cancer. It’s a portable glove with piezoelectric crystals on the palm of the hand that produce ultrasound to screen for breast cancer that comes handy with a software app that does the diagnosis.

WHY ARE WE DOING THIS

Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries (Coleman et al., 2008). The low survival rates in less developed countries can be explained mainly by the lack of early detection programmes, resulting in a high proportion of women presenting with late-stage disease, as well as by the lack of adequate diagnosis and treatment facilities.
To reduce barriers to health access for timely life saving treatment.
To accelerate the rate of early breast cancer detection.
Prototyping
65%
Testing
55%
Team Commitment
100%
Research
70%

OUR PARTNERS